The above results indicate that CSGALNACT2 not only plays an inhibitory role in ovarian high-grade serous cancer cells but also has an inhibitory effect in ovarian endometrioid adenocarcinoma cells. The gene discussed is CSGALNACT2; the disease is ovarian endometrioid adenocarcinoma.